Sanofi India Limited has informed the Exchange regarding Notice of Postal Ballot for appointment of Directors
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi India has sent out a postal ballot notice to shareholders seeking approval for three director appointments via remote e-voting (13 August to 11 September 2025). The key item is the appointment of Mr. Rachid Ayari (existing Whole-time Director & CFO since December 2023) as Interim Managing Director for 6 months from 21 July 2025 to 20 January 2026, following the departure of Mr. Rodolfo Hrosz who ceased to be Managing Director on 30 April 2025. The company is still searching for a permanent MD. Additionally, Mr. Mahadev Gawade, a pharma operations veteran with over 20 years of experience (previously with Sandoz India), is being appointed as Director and Whole-time Director for 3 years effective 11 August 2025. His proposed remuneration includes a basic salary of Rs 56 lakh per annum plus allowances and a target performance bonus of Rs 28 lakh per annum.
This is a routine governance exercise but signals an ongoing leadership transition at Sanofi India after the previous MD's exit in April 2025. The interim MD arrangement provides continuity while a permanent CEO is being sought. Shareholders should review and vote on the resolutions before 11 September 2025; minimal near-term stock impact expected as these are internal governance steps.